ArticleBMC pharmacology & toxicology2013

Glibenclamide inhibits cell growth by inducing G0/G1 arrest in the human breast cancer cell line MDA-MB-231.

Mariel Núñez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.